Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Cells, Auditory | 3 | 2017 | 65 | 0.680 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 31 | 0.490 |
Why?
|
| Cell Membrane | 1 | 2016 | 470 | 0.420 |
Why?
|
| Antioxidants | 1 | 2015 | 333 | 0.380 |
Why?
|
| Trehalose | 2 | 2018 | 20 | 0.280 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2437 | 0.270 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 85 | 0.190 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 17 | 0.160 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 58 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2018 | 12 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 193 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 210 | 0.140 |
Why?
|
| Length of Stay | 1 | 2023 | 1380 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 196 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 280 | 0.140 |
Why?
|
| Hearing Loss | 2 | 2017 | 211 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 373 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4751 | 0.130 |
Why?
|
| Retinal Degeneration | 1 | 2018 | 103 | 0.130 |
Why?
|
| Mental Health Services | 1 | 2020 | 269 | 0.130 |
Why?
|
| Autophagy | 2 | 2018 | 426 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 815 | 0.130 |
Why?
|
| Electric Capacitance | 1 | 2016 | 15 | 0.130 |
Why?
|
| Gerbillinae | 1 | 2016 | 55 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 53 | 0.120 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 51 | 0.120 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2016 | 69 | 0.120 |
Why?
|
| Cochlea | 1 | 2016 | 88 | 0.120 |
Why?
|
| Electrophysiology | 1 | 2016 | 269 | 0.120 |
Why?
|
| Doxycycline | 1 | 2016 | 120 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 294 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 866 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 161 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 303 | 0.110 |
Why?
|
| Alleles | 2 | 2017 | 1684 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Movement Disorders | 1 | 2017 | 223 | 0.110 |
Why?
|
| Animals | 10 | 2020 | 34781 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 500 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 279 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2016 | 799 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 309 | 0.100 |
Why?
|
| Organ of Corti | 1 | 2013 | 26 | 0.100 |
Why?
|
| Mice | 7 | 2020 | 18460 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 408 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2221 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1558 | 0.090 |
Why?
|
| Neurons | 3 | 2017 | 1998 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2013 | 812 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2013 | 215 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1339 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 311 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1519 | 0.080 |
Why?
|
| Brain | 3 | 2018 | 3175 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1248 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 654 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1017 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6440 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 981 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1131 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3351 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2443 | 0.060 |
Why?
|
| Insect Hormones | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2018 | 587 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2005 | 117 | 0.060 |
Why?
|
| Astrocytes | 2 | 2018 | 269 | 0.060 |
Why?
|
| Rehabilitation Centers | 1 | 2023 | 28 | 0.050 |
Why?
|
| Muscle Relaxants, Central | 1 | 2023 | 39 | 0.050 |
Why?
|
| Baclofen | 1 | 2023 | 45 | 0.050 |
Why?
|
| Rhizotomy | 1 | 2023 | 18 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2023 | 74 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2023 | 461 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3860 | 0.040 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 2020 | 35 | 0.040 |
Why?
|
| Humans | 5 | 2023 | 131924 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 550 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2018 | 13 | 0.040 |
Why?
|
| Vacuoles | 1 | 2018 | 29 | 0.040 |
Why?
|
| Male | 7 | 2023 | 64870 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2018 | 41 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 88 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 506 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 123 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 40 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 107 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 429 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 166 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 261 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 167 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 173 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 385 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 397 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 731 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 420 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1572 | 0.030 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2013 | 4 | 0.030 |
Why?
|
| Female | 5 | 2023 | 70584 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2013 | 7 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1608 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 165 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 861 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 112 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 933 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 139 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1183 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 149 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 862 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 349 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 440 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1011 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1033 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 994 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12991 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 14732 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 1035 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2912 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4680 | 0.020 |
Why?
|
| Orthoptera | 1 | 2005 | 1 | 0.020 |
Why?
|
| Juvenile Hormones | 1 | 2005 | 4 | 0.020 |
Why?
|
| Manduca | 1 | 2005 | 6 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1960 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2005 | 22 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17374 | 0.010 |
Why?
|
| Insecta | 1 | 2005 | 64 | 0.010 |
Why?
|
| Adolescent | 1 | 2023 | 20535 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2005 | 155 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11648 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 4703 | 0.010 |
Why?
|
| Child | 1 | 2023 | 25761 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4526 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 846 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1693 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1672 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2091 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1028 | 0.010 |
Why?
|